Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EZETIMIBE\ROSUVASTATIN: 329 Adverse Event Reports & Safety Profile

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy
329
Total FAERS Reports
14 (4.3%)
Deaths Reported
138
Hospitalizations
329
As Primary/Secondary Suspect
43
Life-Threatening
16
Disabilities

First Report: 20000101 · Latest Report: 20250728

What Are the Most Common EZETIMIBE\ROSUVASTATIN Side Effects?

#1 Most Reported
Myalgia
58 reports (17.6%)
#2 Most Reported
Acute kidney injury
24 reports (7.3%)
#3 Most Reported
Blood creatine phosphokinase increased
17 reports (5.2%)

All EZETIMIBE\ROSUVASTATIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myalgia 58 17.6% 0 9
Acute kidney injury 24 7.3% 0 12
Arthralgia 17 5.2% 0 0
Blood creatine phosphokinase increased 17 5.2% 1 11
Leriche syndrome 16 4.9% 0 16
Muscle spasms 16 4.9% 0 0
Peripheral arterial occlusive disease 16 4.9% 0 16
Asthenia 14 4.3% 0 7
Drug abuse 14 4.3% 0 8
Hepatic cytolysis 12 3.7% 1 6
Metabolic acidosis 12 3.7% 0 6
Drug reaction with eosinophilia and systemic symptoms 11 3.3% 3 11
Dyspnoea 11 3.3% 0 4
Hyperkalaemia 11 3.3% 0 2
Ischaemic nephropathy 11 3.3% 0 11
Muscular weakness 11 3.3% 1 5
Rhabdomyolysis 11 3.3% 0 10
Spleen ischaemia 11 3.3% 0 11
Ulnar nerve injury 11 3.3% 0 11
Peripheral artery bypass 10 3.0% 0 10

Who Reports EZETIMIBE\ROSUVASTATIN Side Effects? Age & Gender Data

Gender: 26.8% female, 73.2% male. Average age: 65.8 years. Most reports from: FR. View detailed demographics →

Is EZETIMIBE\ROSUVASTATIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2000 1 0 0
2010 1 0 0
2012 2 0 0
2016 6 0 1
2017 9 0 3
2018 7 0 2
2019 8 0 0
2020 7 0 3
2021 16 0 3
2022 33 6 13
2023 53 1 22
2024 92 5 53
2025 18 1 11

View full timeline →

What Is EZETIMIBE\ROSUVASTATIN Used For?

IndicationReports
Product used for unknown indication 134
Dyslipidaemia 55
Hypercholesterolaemia 41
Coronary artery disease 12
Hyperlipidaemia 11
Ischaemic heart disease prophylaxis 7
Blood cholesterol increased 6
Type iia hyperlipidaemia 6
Myocardial ischaemia 5

EZETIMIBE\ROSUVASTATIN vs Alternatives: Which Is Safer?

EZETIMIBE\ROSUVASTATIN vs EZETIMIBE\SIMVASTATIN EZETIMIBE\ROSUVASTATIN vs EZOGABINE EZETIMIBE\ROSUVASTATIN vs FACTOR XIII CONCENTRATE EZETIMIBE\ROSUVASTATIN vs FAM-TRASTUZUMAB DERUXTECAN-NXKI EZETIMIBE\ROSUVASTATIN vs FAMCICLOVIR EZETIMIBE\ROSUVASTATIN vs FAMOTIDINE EZETIMIBE\ROSUVASTATIN vs FAMOTIDINE\IBUPROFEN EZETIMIBE\ROSUVASTATIN vs FARICIMAB EZETIMIBE\ROSUVASTATIN vs FARICIMAB-SVOA EZETIMIBE\ROSUVASTATIN vs FARICIMAB\FARICIMAB-SVOA

Official FDA Label for EZETIMIBE\ROSUVASTATIN

Official prescribing information from the FDA-approved drug label.